777 related articles for article (PubMed ID: 27585367)
1. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
[TBL] [Abstract][Full Text] [Related]
2. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
4. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
[TBL] [Abstract][Full Text] [Related]
5. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
6. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
[TBL] [Abstract][Full Text] [Related]
7. Tear Luminex Analysis in Dry Eye Patients.
Zhao H; Li Q; Ye M; Yu J
Med Sci Monit; 2018 Oct; 24():7595-7602. PubMed ID: 30356032
[TBL] [Abstract][Full Text] [Related]
8. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
[TBL] [Abstract][Full Text] [Related]
9. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
[TBL] [Abstract][Full Text] [Related]
10. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
[TBL] [Abstract][Full Text] [Related]
11. Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection.
Balne PK; Agrawal R; Au VB; Lee B; Loo E; Tong L; Ghosh A; Teoh SC; Connolly J; Tan P
Data Brief; 2017 Feb; 10():14-16. PubMed ID: 27942559
[TBL] [Abstract][Full Text] [Related]
12. sPLA
Wei Y; Asbell PA
Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
[TBL] [Abstract][Full Text] [Related]
13. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
14. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Chen Y; Mallem K; Asbell PA; Ying GS
Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
[TBL] [Abstract][Full Text] [Related]
15. Impact of Low Humidity on Damage-associated Molecular Patterns at the Ocular Surface during Dry Eye Disease.
Alven A; Lema C; Redfern RL
Optom Vis Sci; 2021 Nov; 98(11):1231-1238. PubMed ID: 34510151
[TBL] [Abstract][Full Text] [Related]
16. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.
Wei Y; Gadaria-Rathod N; Epstein S; Asbell P
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8327-36. PubMed ID: 24204044
[TBL] [Abstract][Full Text] [Related]
17. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests.
VanDerMeid KR; Su SP; Ward KW; Zhang JZ
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1512-8. PubMed ID: 22323462
[TBL] [Abstract][Full Text] [Related]
18. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
[TBL] [Abstract][Full Text] [Related]
19. Trefoil factor family peptide 3 (TFF3) is upregulated under experimental conditions similar to dry eye disease and supports corneal wound healing effects in vitro.
Schulze U; Hampel U; Sel S; Contreras-Ruiz L; Schicht M; Dieckow J; Diebold Y; Paulsen F
Invest Ophthalmol Vis Sci; 2014 May; 55(5):3037-42. PubMed ID: 24713479
[TBL] [Abstract][Full Text] [Related]
20. Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye.
Chhadva P; Lee T; Sarantopoulos CD; Hackam AS; McClellan AL; Felix ER; Levitt RC; Galor A
Ophthalmology; 2015 Aug; 122(8):1675-80. PubMed ID: 25983214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
